PEPTIDE INHIBITORS OF BCR-ABL OLIGOMERIZATION

In one aspect, the invention relates to peptides comprising the Bcr-Abl coiled-coil oligomerization domain and an alpha helix stabilizing moiety, mutant forms thereof, truncated forms thereof, derivatives thereof, and related peptides, which are useful as inhibitors of the Bcr-Abl chimeric protein;...

Full description

Saved in:
Bibliographic Details
Main Authors LIM, Carol, DIXON, Andrew, S, BRUNO, Benjamin, J, MILLER, Geoffrey, D
Format Patent
LanguageEnglish
French
German
Published 22.03.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:In one aspect, the invention relates to peptides comprising the Bcr-Abl coiled-coil oligomerization domain and an alpha helix stabilizing moiety, mutant forms thereof, truncated forms thereof, derivatives thereof, and related peptides, which are useful as inhibitors of the Bcr-Abl chimeric protein; pharmaceutical compositions comprising the compounds; and methods of treating hyperproliferative disorders associated with Bcr-Abl using the compounds and compositions. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
Bibliography:Application Number: EP20150768071